UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000027904 |
|---|---|
| Receipt number | R000031946 |
| Scientific Title | A proof-of-concept clinical trial to evaluate the efficacy and safety of combined use of cefadroxil and tyrosine kinase inhibitors in minimal residual disease-positive patients with chronic phase chronic myelogenous leukemia |
| Date of disclosure of the study information | 2017/07/15 |
| Last modified on | 2021/07/01 19:35:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/06/23 18:52:01 | ||
| 2 | Update | 2019/03/07 19:51:11 | Recruitment status |
|
| 3 | Update | 2021/07/01 19:28:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 4 | Update | 2021/07/01 19:34:26 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2021/07/01 19:35:06 | Number of participants that the trial has enrolled |
